Event in Progress:
Discover the latest content that has just been published on Research Tree
All the figures and metrics beat expectations, without which the group would probably not have reiterated its FY22 guidance. Good job.
Companies: HelloFresh SE
Unsurprising annual results, but indicators for Q4 suggest that there is (still) no let-up. Reassuring for the new year with signs of a return to normal (COVID-19) and inflation. There are obvious questions about the sustainability of the post-pandemic model, but we continue to see, at least, significant short/mid-term growth drivers.
Hellofresh first disappointed with its 2022 guidance well below expectations, then, during the CMD, with the announcement of a doubling of its investment next year without improving the revenue target expected in the mid-term. A lack of coherence at first sight, but also targets that were previously unachievable without these investments, which we believe are indeed necessary. Perhaps it is even time to get in. There was a similar reaction from investors in August after a disappointment, but fol
The market liked for the Q3 sales beat and the upward revision of revenue guidance for the year. At the current 2.1x FY21 EV/sales vs. peers at 3.8x, we believe the valuation is still attractive at this time.
We initiate coverage of Hellofresh, the global leader in the growing meal-kit market, with a Buy recommendation and 24% upside.
Research Tree provides access to ongoing research coverage, media content and regulatory news on HelloFresh SE. We currently have 52 research reports from 3 professional analysts.
Weekly round-up of AIM-listed healthcare news. Intelligent Ultrasound, Inspiration Healthcare, Agronomics, CareTech Holdings, e-therapeutics, ABCAM, EKF Diagnostics, HUTCHMED (China), Benchmark Holdings, Totally, ImmuPharma, Open Orphan, Destiny Pharma, Polarean Imaging, Induction Healthcare.
Companies: ANIC RUA CREO GENI HEIQ IHC IXI IUG OPTI SBTX VAL VLG
Kromek is an enabling technology provider to the medical imaging market in particular. It is a commercial-stage company with two significant high growth opportunities: as a critical component supplier of cadmium zinc telluride (CZT) detectors to the advanced medical imaging market (next generation SPECT and CT modalities); and as a manufacturer of state-of-the-art radiation detectors to global government and Homeland Security agencies. High barriers to entry, given c.£130m invested since incepti
Companies: Kromek Group Plc
Companies: Kromek Group Plc (KMK:LON)Synairgen plc (SNG:LON)
Gresham has announced a landmark win with a key Tier 1 existing banking customer worth up to £6.3m over a minimum of c. 5 years. Building on an initial 3 year contract signed in June 2020 worth £1.7m over 3 years, the scope of work has materially expanded with Clareti being chosen as the customer’s single enterprise platform across its whole UK business, covering retail accounts, cards, payments and as well commercial banking. Clareti will replace manual processes and, of particular note, legacy
Companies: Gresham Technologies plc
Companies: 4BB FOUR ARB IOF
FY21 revenues of £20.5m were 5.1% ahead of forecasts, with gross margin increased 2.2% to 55.9% and PBT up 17% to £3.5m. R&D is accelerating with a focus on increasing the product range at double the previous frequency and within half the time. Order in-take is strong, though revenues in FY22E will be affected by the widely reported electronic component availability. However, with this growing order in-take and significant balance sheet strength, Concurrent is strongly positioned to continue to
Companies: Concurrent Technologies Plc
Weekly round-up of AIM-listed healthcare news. Agronomics, Eden Research, IXICO, HeiQ, Trellus Health, NetScientific, Circassia, 4basebio, Fusion Antibodies, Surgical Innovations Group, Yourgene Health, Abingdon Health, Verici Dx, Poolbeg Pharma, Omega Diagnostics
Brave Bison has released its full-year results in-line with previous guidance. The company has had a transformational year with the new management team putting the business on a firmly profitable path having turned a statutory profit in FY21A for the first time along with 50% revenue growth. They carried out their valuable acquisition of Greenlight, a UK digital advertising and technology firm, which broadened and complemented the Brave Bison offering. Today, the company have announced a further
Companies: Brave Bison Group Plc
Companies: ARB D4T4 ORPH SPE
Companies: Cerillion Plc
Having updated in April that FY22 revenues and operating profits were expected to be in line with consensus, Eckoh today updates that operating profits grew strongly in the period and will now be ahead of consensus. Revenues are expected to be in line. We suspect this means operating profits will be slightly above £5.0m compared to our forecasts of £4.9m. This de-risks our FY23 forecasts, where we are looking for AOP of £7.7m. We are forecasting FY23 AOP of £5.9m from the existing business, up f
Companies: Eckoh plc
Despite lingering lockdown headwinds, FYJan22 saw continued strong growth for Smartspace’s two SaaS businesses, SwipedOn (visitor, employee and desk management) and Space Connect (meeting room and desk management), driving combined ARR up 64% organic to £4.9m. SwipedOn ARR grew 57% yoy (>85% of total ARR) with Space Connect ARR up almost threefold. Encouraging trading through to end April (ARR rose to £5.5m) underpins Smartspace’s continued expectations for “further strong growth in FY23”. Key d
Companies: Smartspace Software Plc
Dish of the day Joiners: GS Chain (GSC) has joined the Main Market (Standard). GS Chain intends to identify opportunities within the technology sector, to conduct the necessary due diligence and subsequently complete an Acquisition. The Company is direct listing 399,985,888 Ordinary Shares on the Official List. Market capitalisation at 1p is £3,999,858.88. Leavers: No Leavers Today. What’s cooking in the IPO kitchen? According to CITY A.M online marketplace Beauty Bay has recruited bankers to lo
Companies: FPO NMT RBD SNT SOLG HUI FCRM AEX
Dish of the day Joiners: Lekoil, the oil and gas exploration and production Company with a focus on Nigeria and West Africa has joined the Access Segment of the AQSE Growth Market. The Company was previously listed on AIM (LEK.L), however, Ordinary Shares have been suspended from trading on AIM since October 2021. Leavers: No Leavers Today. What’s cooking in the IPO kitchen? Psych Capital PLC, intends to list on the AQSE Growth Market. Psych operates the Psych Platform (a business-to-business ne
Companies: CZA AXL AEE CORA D4T4 EKF ORPH PWM PPH SYM
Companies: CMO Group PLC
Share: